BioSpace News Archive

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology, announced today that it will report its first quarter 2020 financial results and provide a business update on Thursday, May 14, 2020 before the open of the U.S. financial markets.

Global Genes to Host RARE Drug Development Symposium Virtual Event

Conference Call to be Held on May 14, 2020 ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2020 an

Company advances mission to combat AML, as this research comes on the heels of its Phase 3 trial, actively enrolling globally

Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced first quarter 2020 financial results and business updates. First Quarter and Recent Highlights Validive Phase 2b/3 Clinical Trial Monopar, in response to the current COVID-19 pandemic and its effe

Rx3000 ® UV Light Air Purifier production shifts to Massachusetts to ensure quality, fast production & delivery Rx3000 inactivates on first pass 99.97% of harmful airborne viruses & bacteria. CDC states UV-C light is one of the most promising methods for Coronavirus (CoV-2) disinfection of face masks. Worcester, MA, May 07, 2020 (GLOBE NEWSWIRE) -- Vystar Corp. (OTCQB: VYST) has shifted to Massachusetts production of its Rx3000 ® , a hybrid ultraviolet (UV)-light air purif

Strata Oncology, a precision oncology company advancing molecular indications for cancer therapies, announced three studies highlighting data featuring its comprehensive genomic profiling assay StrataNGSTM will be presented at the 2020 Annual Meeting of the American Society of Clinical Oncology, taking place digitally from May 29 – May 31.

Wize Pharma , Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has completed treating patients in its Phase IV clinical tri

EG Group and the American Cancer Society have announced that their nationwide partnership to drive funding for life-saving programs and services provided by the American Cancer Society has generated $252,394 in charitable donations.

- Total 2020 Charitable Grants to Date Approach $17 Million - - Lifetime Giving Approaches $112 Million -